Adalimumab

ID 11409574 · Portal BASE
Price
Base Price
€136,800 .00
Effective Price
€136,800 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33690000
Location
Portugal, Lisboa, Loures
Bidder Count
—
Winner
AMGEN-BIO-FARMACÊUTICA LDA
NIF 502942959
Company
Dates
Publication
08 May 2025
Celebration
28 Jan 2025
Contracting Entity
Unidade Local de Saúde de Loures-Odivelas, EPE
NIF 516726862
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 90 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
1245
Supplier
44
Number of Awards
7
Rule
A1 repeat direct award: 7 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
08 May 2025
Signing Date
28 Jan 2025
Days Late
100
Rule
A2/A3 late publication: 100 days after signing (threshold: 10)
Detected 2026-03-06